semaglutide news today 2025 The Trump administration is preparing to launch a pilot program that would cover weight loss drugs like Ozempic and Wegovy through Medicare and Medicaid. This could be a game-changer for millions of In the OASIS 4 phase

"Were in the middle of a structural shift in how consumers approach fooda convergence of GLP-1 driven awareness and broader economic pressures that are reshaping expectations around nutrition and value, says Lasso CEO Mike Messersmith

Semaglutide GLP-1 was initially developed for type 2 diabetes but has proven to be highly effective in aiding weight loss

You can tell it is handled properly

This mechanistic clarity makes Semaglutide the appropriate reference compound for establishing baseline GLP-1 pathway effects before investigating what dual or triple agonism adds

The table below highlights the key differences between Semaglutide, Tirzepatide, and Retatrutide